Gemcitabine HCl Market

Gemcitabine Hydrochloride is the hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity.

Gemcitabine HCl Market contains market size and forecasts of Gemcitabine HCl in global, including the following market information:

• Global Gemcitabine HCl Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Gemcitabine HCl Market Sales, 2017-2022, 2023-2028, (Kg)
• Global top five Gemcitabine HCl companies in 2021 (%)

The global Gemcitabine HCl market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gemcitabine HCl include Sun Pharmaceutical Industries, Tapi Teva, Shilpa Medicare, Huachu Industrial, Jinkang Pharmaceutical Technology, Jierui Pharmaceutical, HISUN, FUAN PHARMACEUTICAL and Zhendong Group and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Gemcitabine HCl manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gemcitabine HCl Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Gemcitabine HCl Market Segment Percentages, by Type, 2021 (%)

• Above 98%
• Below 98%

Global Gemcitabine HCl Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Gemcitabine HCl Market Segment Percentages, by Application, 2021 (%)

• Non-Small Cell Lung Cancer
• Pancreatic Cancer
• Breast Cancer
• Other

Global Gemcitabine HCl Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Gemcitabine HCl Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Gemcitabine HCl revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Gemcitabine HCl revenues share in global market, 2021 (%)
• Key companies Gemcitabine HCl sales in global market, 2017-2022 (Estimated), (Kg)
• Key companies Gemcitabine HCl sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sun Pharmaceutical Industries
• Tapi Teva
• Shilpa Medicare
• Huachu Industrial
• Jinkang Pharmaceutical Technology
• Jierui Pharmaceutical
• HISUN
• FUAN PHARMACEUTICAL
• Zhendong Group
• CHIATAI QINGJIANG